Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 380.00
-1.00 (-0.26%)
Jul 16, 2026, 12:21 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 20.75 billion as of July 15, 2026. Its market cap has decreased by -8.41% in one year.
Market Cap
20.75B
Enterprise Value
19.67B
Revenue
2.04B
Ranking
n/a
PE Ratio
28.71
Stock Price
380.00
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 20.75B, an increase of 1,295.38%. That is a compound annual growth rate of 17.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 20.75B | -3.79% |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.49B |
| CHO Pharma | 22.26B |
| ACRO Biomedical | 18.30B |
| TaiMed Biologics | 17.54B |
| Ever Supreme Bio Technology | 16.49B |
| Lumosa Therapeutics | 16.01B |
| Medigen Vaccine Biologics | 14.81B |
| TCM Biotech International | 14.35B |